Methods
This trial was conducted at the Peking University People’s Hospital from September 22, 2022, to December 21, 2022. The study was approved by the Ethical Review Committee of Peking University People’s Hospital (#2022PHB179-001). Then, it was registered in the Chinese Clinical Trial Registry (ChiCTR2200062017) on 19/07/2022.